Home » Topics » Disease categories and therapies » Urology

Urology
RSS

AEterna Zentaris reports results from phase III Z-036 efficacy trial of cetrorelix in BPH

Dec. 10, 2009

Merck & Co. describes beta3-adrenoceptor agonists for urinary incontinence

Dec. 4, 2009

Sitaxentan reduces post-CPB acute kidney injury in porcine model

Dec. 3, 2009

Novartis claims MMP inhibitors for the treatment of Alport syndrome

Dec. 2, 2009

Genzyme reports results from phase II/III trial of GENZ-644470 in hyperphosphatemia

Nov. 19, 2009

Benefit of PRX-032 in benign prostatic hyperplasia lasts at least one year

Nov. 13, 2009

PBI-1402 shows renoprotective effects in mouse model of acute nephrotoxicity

Nov. 12, 2009

Azathioprine superior to mycophenolate mofetil as maintenance therapy for ANCA-AAV

Nov. 10, 2009

Meloxicam is an effective treatment for refractory nocturia in BPH patients

Nov. 5, 2009

Four-year COMBAT data show BPH improvement with Duodart

Nov. 5, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...